February 01, 2006
In furthering it's strength in transdermal drug delivery, Teikoku signs an agreement with Altea Therapeutics to develop and commercialize a new patch therapy for managing Parkinson's Disease, utilizing Altea Therapeutics' PassPort technology. For details, see Altea Therapeutics' Press Release
Teikoku Pharma
USA, Inc.
1718 Ringwood Ave
San Jose, CA 95131
USA
Main: (408) 501-1800
Fax: (408) 501-1900
info@teikokuusa.com
Click here to download
the Teikoku Brochure
in PDF format.
Visit Teikoku Seiyaku's
website.
